Skip to content

Clinical and Radiographic Evaluation of Maxillary Sinus Augmentation using Apatite Carbonate with or without Platelet Rich Fibrin Simultaneously with Dental Implant Placement

Clinical and Radiographic Evaluation of Maxillary Sinus Augmentation using Apatite Carbonate with or without Platelet Rich Fibrin Simultaneously with Dental Implant Placement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202509825697094
Enrollment
16
Registered
2025-09-09
Start date
2024-09-23
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health

Interventions

Maxillary sinus augmentation using apatite carbonate with addition of PRF and implant placement
Maxillary sinus augmentation using apatite carbonate with implant placement and without PRF

Sponsors

Mostafa medhat ahmed kamar
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Males and females aging from 30-50 years old. • ASA I ( normal healthy patients). bilaterally. • Patients having partial edentulism in the posterior region of the maxilla •Edentulous sites consists of native non augmented bone. • Horizontal ridge dimension minimum of 5mm as revealed form pre operative radiographic CBCT •Vertical ridge dimension less than 5mm as revealed form pre-operative radiographic CBCT • Bone quality of D2 or D3. • Enough inter-arch distance.

Exclusion criteria

Exclusion criteria: • Patients with active acute infection or residual lesion related to the edentulous sites. • Maxillary sinus pathosis •Remaining root dislodged in the maxillary sinus. • Patients that lack a stable occlusion or has parafunctional habits. • Patients with poor oral hygiene that are not amenable to motivation and improvement. • Patients suffering from diseases ( ASA II , ASA III ) or taking drugs affecting the bone healing (as uncontrolled Diabetes Mellitus, osteoporosis, Paget’s disease and bisphosphonates) • Smokers who smoke more than 10 cigarettes a day. • Pregnant or lactating mothers. • Alcohol and drug abuse. • Treatment with radiation therapy in the craniofacial region within the previous 12 months.

Design outcomes

Primary

MeasureTime frame
Presence or absence of intra or postoperative complications - Schneiderian membrane perforation occurrence, intraoperative bleeding, epistaxis, postoperative sinusitis, periimplantitis

Secondary

MeasureTime frame
Postoperative pain; Postoperative edema

Countries

Egypt

Contacts

Public ContactMostafa Kamar

TA

Mostafakamar4@gmail.com+201005727291

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026